{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T21:14:18Z","timestamp":1774732458243,"version":"3.50.1"},"reference-count":70,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/14728214.2017.1293650","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T09:03:57Z","timestamp":1486976637000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["An update on emerging therapies for urinary tract infections"],"prefix":"10.1080","volume":"22","author":[{"given":"Aneela","family":"Majeed","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, University of Arizona, Tucson, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumaiah","family":"Alarfaj","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Arizona, Tucson, AZ, USA; Faculty, Princess Nourah bint Abdulrahman University, College of Pharmacy, Department of Pharmaceutical Practice, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabih","family":"Darouiche","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Baylor College of Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayar","family":"Mohajer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University of Arizona, Tucson, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/0924-8579(94)90038-8"},{"issue":"1","key":"CIT0002","first-page":"24","volume":"18","author":"Camesano TA","year":"2007","journal-title":"Agro Food Ind Hi Tech"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01054-9"},{"issue":"3","key":"CIT0004","first-page":"iii25","volume":"65","author":"Pallett A","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"CIT0005","unstructured":"World Health Organization. (2014). Antimicrobial resistance global report on surveillance: 2014 summary. Available at: http:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.11.003"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1998.1609"},{"issue":"1","key":"CIT0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/42.1.121","volume":"42","author":"Fournier B","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/nature10388"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-009-0833-2"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh414"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.suppl_1.67"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.897-900.2003"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2002.26605"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004201.pub2"},{"issue":"3","key":"CIT0019","first-page":"271","volume":"41","author":"Conway LJ","year":"2012","journal-title":"J Crit Care Med"},{"key":"CIT0020","first-page":"AAC","author":"Castanheira M","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"CIT0021","first-page":"19","volume":"19","author":"Sanchez M","year":"2002","journal-title":"Acad Emerg Med"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00103-9"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.1.41"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05419-11"},{"issue":"9","key":"CIT0025","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","volume":"60","author":"Tamma PD","year":"2015","journal-title":"Clin Infect Dis"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1086\/431676"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1179\/1120009X12Z.00000000016"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2007.40.6.881"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.997206"},{"issue":"5","key":"CIT0031","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/AAC.43.5.1170","volume":"43","author":"Kohler J","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1151-1161.2001"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2010.0052"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.5.685"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr290"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565150-00013"},{"issue":"6","key":"CIT0037","first-page":"681","volume":"133","author":"Taneja N","year":"2011","journal-title":"Indian J Med Res"},{"key":"CIT0038","first-page":"61","volume":"7","author":"Wright WW","year":"1958","journal-title":"Antibiot Annu"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0069-x"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.02.648"},{"key":"CIT0044","unstructured":"Kallen AJ, Hidron AI, Edwards JR, et al. Antibiotic resistance among important gram-negative pathogens causing healthcare-associated infections reported to the national healthcare safety network, 2006-2007 [abstract 376] In: Program and abstracts of the 18th annual scientific meeting of the society for healthcare epidemiology of america, orlando, FL, apr 5-8, 2008"},{"key":"CIT0045","volume-title":"National action plan for combating antibiotic-resistant bacteria","author":"House, White","year":"2015"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0168-2"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62220-0"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.748653"},{"key":"CIT0050","first-page":"AAC","author":"Pitart C","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw378"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw398"},{"key":"CIT0055","first-page":"AAC","author":"Macone AB","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00948-12"},{"key":"CIT0057","first-page":"AAC","author":"Sutcliffe JA","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06187-11"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01614-13"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00366-16"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01614-13"},{"key":"CIT0063","unstructured":"Connolly LE, Serio AW, Riddle VD. et al. Baseline pathogens and patient outcomes in a phase 2 study comparing plazomicin (ACHN-490) to levofloxacin in complicated urinary tract infection (cUTI) including acute pyelonephritis (AP), South San Francisco, CA, USA), BioPharmAdvisors LLC, (Bumpass VA, USA), InClin, Inc. (San Mateo, CA, USA)25th ECCMID, 2015, presentation # O200)"},{"key":"CIT0064","unstructured":"Achaogen. Achaogen announces all objectives met in Phase 2 Plazomicin complicated urinary tract infections study and start of first-in-human study with ACHN-975. http:\/\/www.achaogen.com\/uploads\/news\/id148\/Achaogen_PressRelease_2012\u201305\u201315.pdf"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00711-16"},{"key":"CIT0068","first-page":"dkt178","author":"Livermore DM","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.009"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.009"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01695-15"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.02.2028"},{"key":"CIT0077","unstructured":"GlaxoSmithKline. Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsClinicalTrials.gov, 23 Jan 2013 & 27 Mar 2014 & 3 Sep 2015. http:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT02045797"},{"issue":"1","key":"CIT0080","volume":"3","author":"O'Riordan W","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00527-16"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0384-z"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00833-10"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1052401"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.05.003"},{"key":"CIT0087","first-page":"dkt178","author":"Livermore DM","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7153"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.06.002"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2017.1293650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T08:41:18Z","timestamp":1749976878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2017.1293650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,22]]},"published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/14728214.2017.1293650"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2017.1293650","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}